Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA053486-05
Application #
2095356
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1992-04-01
Project End
1998-03-31
Budget Start
1996-04-01
Budget End
1998-03-31
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
University of Pittsburgh
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213

  Publications

Scioscia, K A; Snyderman, C H; Rueger, R et al. (1997) Role of arachidonic acid metabolites in tumor growth inhibition by nonsteroidal antiinflammatory drugs. Am J Otolaryngol 18:1-8
Snyderman, C H; Malone, J P (1997) Arachidonic acid metabolites in saliva of patients with squamous cell carcinoma of the head and neck. Adv Exp Med Biol 400B:949-54
Milanovich, M R; Snyderman, C H; Wagner, R et al. (1995) Prognostic significance of prostaglandin E2 production by mononuclear cells and tumor cells in squamous cell carcinomas of the head and neck. Laryngoscope 105:61-5
Snyderman, C H; Milanovich, M; Wagner, R L et al. (1995) Prognostic significance of prostaglandin E2 production in fresh tissues of head and neck cancer patients. Head Neck 17:108-13
Snyderman, C H; Abbas, M M; Wagner, R et al. (1995) Inhibition of growth of a murine squamous cell carcinoma by a cyclooxygenase inhibitor increases leukotriene B4 production. Arch Otolaryngol Head Neck Surg 121:1017-20
Malone, J P; Snyderman, C H (1994) Arachidonic acid metabolites in saliva of patients with squamous cell carcinoma of the head and neck. Oral Surg Oral Med Oral Pathol 77:636-40
Snyderman, C H; Klapan, I; Milanovich, M et al. (1994) Comparison of in vivo and in vitro prostaglandin E2 production by squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 111:189-96